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This study was designed in order to investigate the effect of Myrmecodia 
platytyrea (MyP) extract as an anti-hypercholesterolemic agent. The acute 
toxicological test was done by administration of single dose and followed by 
14 days observation on the rat. The subchronic toxicological test was done 
by administration of 28 days repeated dose. Both tests showed that MyP 
water extract was not toxic. The bioassay-guided isolation revealed that the 
MyP water extract containing 2-(2-methylbutyryl) phloroglucinol glucoside 
which reduced 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) activity 
(p<0.05) with inhibition concentration 50 (IC50) of 75 µg/ml. Besides that, 
polysaccharide showed effective concentration 50 (EC50) of 50.5 µg/ml for bile 
acid binding. Meanwhile, rutin actively decreased pancreatic lipase activity 
with IC50 of 130 µg/ml. Moreover, in vivo study results showed that treatment 
of MyP water extract can significantly reduce (p<0.05) low-density lipoprotein 
(LDL) compared to negative control group. The extract significantly increased 
(p<0.05) high-density lipoproteins (HDL) concentration compared to negative 
control group. In addition, MyP water extract increased faecal cholesterol 
and faecal bile compared to normal control group. Lipid peroxidation was 
significantly decreased (p<0.05) in MyP water extract treatment group. 
The extract also decreased the formation of the fatty streak at the aorta and 
significantly decreased (p<0.05) the thickness of foam cell in high cholesterol 
This project aimed to design nanoparticles-in-beads made of alginate, chitosan 
and their derivatives as oral insulin carrier. In the first part of the study, the 
calcium alginate beads were prepared using the vibratory nozzle extrusion 
microencapsulation technique through concurrent core and coat formation 
with chlorpheniramine maleate as a model drug. These beads were coated with 
chitosan/chitosan-oleic acid conjugate of which the latter was synthesized via 
covalent reaction. The formability of beads was optimized through varying 
alginate solution concentration, alginate/chitosan solution flow rate and nozzle 
vibrational frequency. The size, shape, morphology, swelling, erosion, water 
uptake, drug content, drug release and matrix molecular profiles of beads were 
characterized. Spherical discrete coated beads were produced through critical 
interplay of nozzle vibrational frequency and polymeric solution flow rate. 
The conjugate-coated beads had their swelling and water uptake tendency 
negated through the introduction of tripolyphosphate ions as a crosslinking 
agent to attract the conjugate to the alginate core interface for coacervation 
to take place. The drug release propensity of tripolyphosphate-crosslinked, 
chitosan-oleic acid conjugate-coated beads was unexpectedly higher than the 
uncoated beads. This was attributed to reduced drug-alginate interaction as 
a result of alginate coacervating with chitosan-oleic acid conjugate and loss 
of calcium alginate crosslinkage to tripolyphosphate species. In the second 
part of the study, nanoparticles of simple calcium alginate, calcium alginate-
stearic acid, and calcium alginate-C18 conjugate were prepared by nanospray 
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diet (HCD) induced rat. Then, cell culture study using WRL-68 cell 
showed MyP water extract significantly increased (p<0.05) apo lipoprotein 
A-I (Apo A-I), scavenger receptor – B1 (SR-B1) and lecithin: cholesterol 
acyltransferase (LCAT). The extract can significantly reduce (p<0.05) 
lipid droplet formation. Furthermore, MyP water extract also significantly 
increased (p<0.05) the superoxide dismutase (SOD) and catalase (CAT) 
enzymes. In the molecular study, polymerase chain reaction (PCR) array 
was performed on the 84 genes that specifically involved with lipoprotein 
signalling and cholesterol metabolism. The result showed that the treatment 
of MyP water extract can increase the gene expression related to reverse 
cholesterol transport (RCT) process. The treatment of MyP water extract 
did not up-regulate the gene expression of CYP7A1which is important 
in the transformation process of bile acid from cholesterol. Therefore, 
it was suggested that MyP water extract only acted on the bile acid itself 
and not through up-regulation of bile acid transformation related genes. It 
was suggested that the bioactive compound’s synergistic effects which are 
present in MyP water extract also acted as antioxidant and anti-inflammatory. 
It was concluded that MyP water extract might play an important role in the 
prevention of hypercholesterolemia related diseases.
drying technique. Alginate-C18 conjugate was chemically synthesized 
with the aim of introducing a hydrophobic segment to the polymer chain 
for drug release modulation. The nanoparticles size, zeta potential, surface 
morphology, drug content, drug encapsulation efficiency, drug release, matrix 
molecular characteristics, mucus penetration, HT-29 cell line cytotoxicity 
and intracellular trafficking profiles were evaluated. Where applicable, the 
nanoparticles were loaded into calcium alginate beads and had their in vivo 
blood glucose lowering and insulin bioavailability profiles determined. The 
calcium alginate-C18 conjugate nanoparticles were characterized by non-
toxicity, reduced size and zeta potential thus enhanced mucus penetration 
and intracellular trafficking, with minimal insulin readsorption tendency 
as a result of active COOH/COO- sites of alginate being occupied by C18 
conjugate. Loading of such nanoparticles into tripolyphosphate-crosslinked, 
chitosan-oleic acid conjugate-coated beads had their drug release reduced 
in the simulated gastric phase with the majority of insulin being transported 
transmucosally in the form of nanoparticles at the intestinal region. The 
combination of nanoparticles and coated beads increased the blood glucose 
lowering extent of rats synergistically, and insulin bioavailability instead of 
nanoparticles alone.
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